Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
van Duijnhoven
E
E
Department of Internal Medicine, University Hospital Maastricht, The Netherlands.
Christiaans
M
M
Schäfer
A
A
Undre
N
N
van Hooff
J
J
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003928:Diabetic Nephropathies / Q000601:surgery*; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology*; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016559:Tacrolimus